Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sortilin restricts secretion of apolipoprotein B-100 by hepatocytes under stressed but not basal conditions
Donna M. Conlon, … , Nicholas J. Hand, Daniel J. Rader
Donna M. Conlon, … , Nicholas J. Hand, Daniel J. Rader
Published February 3, 2022
Citation Information: J Clin Invest. 2022;132(6):e144334. https://doi.org/10.1172/JCI144334.
View: Text | PDF
Research Article Genetics Vascular biology Article has an altmetric score of 1

Sortilin restricts secretion of apolipoprotein B-100 by hepatocytes under stressed but not basal conditions

  • Text
  • PDF
Abstract

Genetic variants at the SORT1 locus in humans, which cause increased SORT1 expression in the liver, are significantly associated with reduced plasma levels of LDL cholesterol and apolipoprotein B (apoB). However, the role of hepatic sortilin remains controversial, as genetic deletion of sortilin in mice has resulted in variable and conflicting effects on apoB secretion. Here, we found that Sort1-KO mice on a chow diet and several Sort1-deficient hepatocyte lines displayed no difference in apoB secretion. When these models were challenged with high-fat diet or ER stress, the loss of Sort1 expression resulted in a significant increase in apoB-100 secretion. Sort1-overexpression studies yielded reciprocal results. Importantly, carriers of SORT1 variant with diabetes had larger decreases in plasma apoB, TG, and VLDL and LDL particle number as compared with people without diabetes with the same variants. We conclude that, under basal nonstressed conditions, loss of sortilin has little effect on hepatocyte apoB secretion, whereas, in the setting of lipid loading or ER stress, sortilin deficiency leads to increased apoB secretion. These results are consistent with the directionality of effect in human genetics studies and suggest that, under stress conditions, hepatic sortilin directs apoB toward lysosomal degradation rather than secretion, potentially serving as a quality control step in the apoB secretion pathway in hepatocytes.

Authors

Donna M. Conlon, Carolin V. Schneider, Yi-An Ko, Amrith Rodrigues, Kathy Guo, Nicholas J. Hand, Daniel J. Rader

×

Figure 2

Hepatic overexpression of sortilin reduces TG but not apoB-100 secretion in basal chow-fed mice.

Options: View larger image (or click on image) Download as PowerPoint
Hepatic overexpression of sortilin reduces TG but not apoB-100 secretion...
8-week-old C57BL/6J mice were injected with either null or mSort AAV.TBG and maintained on a chow diet for 12 weeks. (A) Hepatic Sort1 mRNA was measured by qRT-PCR. ****P <0.0001 by t test. (B) Liver homogenate was Western blotted for sortilin and actin protein. (C) Mice were injected i.v. with Pluronic and 35S Met/Cys and bled every 30 minutes for 2 hours. Plasma TG was measured and compared using repeated-measures ANOVA. **P <0.005 by 2-way ANOVA. (D) TG secretion rate was calculated as the mg/dL/h. *P < 0.05 by t test. (E–G) Total plasma from each mouse at 60, 90, and 120 minutes after injection was subjected to autoradiography, and 35S-labeled apoB-100 was quantified by liquid scintillation counting. (H) Total plasma from the 2-hour postinjection time point was subjected to autoradiography, and 35S-labeled Alb, apoE, and apoA-I bands were counted. n = 8–9/group. (I) 2-hour plasma was pooled and separated by sucrose density ultracentrifugation and then taken off in 11 fractions, and total apoB-100 was measured by Western blotting. Data are presented as percentage of total apoB-100 in each fraction for each group. *P < 0.05 as compared with null AAV by Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
17 readers on Mendeley
See more details